BPA Call 36E79718A0010-36C24718K0036
Award Date 4/6/18
Potential Completion Date 9/30/18
Potential Value $82K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for a Blanket Purchase Agreement (BPA) call from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 7 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of Prolastin, a pharmaceutical product, with a potential value of $125,209.92. The contract does not utilize any small business set-asides and is a Firm Fixed...
- This is a federal contract award made by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the product PROLASTIN, a pharmaceutical, and is a Blanket Purchase Agreement (BPA) call order under the VA's Pharmaceuticals and Drugs GSA Schedule. The contract has a ceiling value of $161,722.32 and a period of performance ending on...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Grifols Therapeutics LLC, a for-profit pharmaceutical manufacturer and supplier, for the provision of 1,000mg vials of the drug Prolastin. The potential value of this award is $310,527.76. The contract does not utilize any small business set-asides. This award is under the Pharmaceuticals and Drugs GSA Schedule 61 contract...
- This is a federal contract award for PROLASTIN to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $219,999.96, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20 and did not utilize any small business set-asides. The contract is a delivery order under the Pharmaceuticals and Drugs General Services Administration (GSA) Federal Supply...
- This federal contract award, valued at $161,280.00, was issued by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA) to the prime contractor Grifols Therapeutics LLC. The contract is a delivery order placed against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) held by Grifols. The award is for the provision of pharmaceutical medication, with no set-aside designation. Grifols Therapeutics LLC is a for-profit manufacturer and...
- This federal contract award was made by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of medication, specifically pharmaceuticals such as Prolastin, Prolastin-C, and immune globulin. The contract type is a Blanket Purchase Agreement (BPA) Call, with a Firm Fixed Price pricing structure. The...
- This is a contract award by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is a Blanket Purchase Agreement (BPA) call for the delivery of the pharmaceutical product Prolastin, with a potential value of $110,496.96. The contract is not designated as a set-aside and utilizes the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) as the parent...
- This is a Firm Fixed Price call order under a Blanket Purchase Agreement (BPA) between the Department of Veterans Affairs (VA) and Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $84,785.28, is for the VA to order Prolastin-C, a plasma-derived alpha1-proteinase inhibitor, for Fiscal Year 2018. The contract does not have a small business set-aside. Grifols is the prime contractor and has provided similar...
- This is a $93,183.36 firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the U.S. Department of Veterans Affairs to Grifols Therapeutics LLC, a manufacturer of pharmaceuticals and biopharmaceuticals. The contract is for the provision of the pharmaceutical product Prolastin to the Veterans Integrated Service Network 7 for the 2018 fiscal year. The contract was awarded on March 29, 2018 and has an ultimate completion date of September 30, 2018. This contract was not set...
- This federal contract award is a delivery order issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The order is for various pharmacy supplies and pharmaceuticals, including Prolastin, Prolastin-C, and immune globulin, under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. The total...